Addleshaw Goddard and Henderson Chambers secure indemnity costs following judgment being entered for GSK in the long-running Seroxat Pharmaceutical Group Action
Seroxat Litigation: Judgment for GSK with indemnity costs and £4.5m interim payment in landmark product liability group action success
On 3 July 2020 the judgment of Lambert J was handed down in the High Court in the Seroxat Group Litigation Bailey and others v GlaxoSmithKline  EWHC 1766 (QB). Following GSK’s success in the Court of Appeal on the question of the scope of the Claimants’ claims, GSK applied for judgment on the basis that the claims were legally untenable. Judgment has been entered in GSK’s favour along with an award of costs, in part on an indemnity basis.
Malcolm Sheehan QC, Adam Heppinstall and James Williams of Henderson Chambers appeared for GSK. They were instructed by Addleshaw Goddard LLP, where the team was led by Louisa Caswell, and barristers from Henderson Chambers led by Charles Gibson QC, have acted for GSK throughout the litigation.
A copy of the judgment and alerter can be found on the attached links.